Brca2 abrogation engages with the alternative lengthening of telomeres via break-induced replication

The FEBS Journal
Mi-Sun KwonHyunsook Lee

Abstract

A subset of cancer cells maintains their telomeres without telomerase through the recombination-based alternative lengthening of telomeres (ALT) pathway. Currently, it is not yet clear in what context ALT is induced and how the pathway choice is made. Here, we show that abrogation of Brca2 reinforces break-induced replication (BIR) and engages with ALT pathway. Brca2 depletion in telomerase-null mouse cells alleviated the growth defect, accompanied by telomere elongation, suggesting the induction of ALT. We also found that Brca2-depleted telomerase-null cells exhibited dynamic clustering of telomeres from G2 phase in Promyelocytic Nuclear (PML) bodies. For Brca2-deficient ALT induction, Rad51 was dispensable but Mre11 and Rad52 were required. Congruently, conservative telomeric DNA synthesis was apparent in mitosis, indicating that the absence of Brca2 directed towards Rad52-mediated BIR. Collectively, we propose that Brca2 abrogation can instigate ALT tumourigenesis through the induction of BIR. This study implies that inhibitors of BIR may be useful for BRCA2-associated ALT-type cancers. Assessing ALT features may be considered for the tailored therapy of BRCA2-associated cancers.

References

Jul 14, 1998·Molecular Cell·K J PatelA R Venkitaraman
Jul 15, 1999·Cytometry·S S PoonP M Lansdorp
Feb 12, 2000·Molecular and Cellular Biology·A SmogorzewskaT de Lange
Feb 19, 2002·Oncogene·Jeremy D HensonRoger R Reddel
Dec 19, 2003·Genes & Development·Mikhail LomonosovAshok R Venkitaraman
Apr 28, 2004·Cell·Madalena TarsounasStephen C West
Aug 12, 2005·Nucleic Acids Research·Yasukazu YonetaniMistuyoshi Yamazoe
Dec 11, 2007·Oncogene·T Thorslund, S C West
Jan 8, 2008·Nature Chemical Biology·Aude DupréJean Gautier
Oct 29, 2008·Annual Review of Pathology·Ashok R Venkitaraman
May 27, 2009·The Journal of Cell Biology·Wei-Qin JiangRoger R Reddel
Nov 26, 2009·Nature Structural & Molecular Biology·Anthony J CesareRoger R Reddel
Mar 31, 2010·Nature Reviews. Genetics·Anthony J Cesare, Roger R Reddel
Nov 16, 2010·Nature Structural & Molecular Biology·Sophie BadieMadalena Tarsounas
Oct 25, 2011·Mutation Research·Sigridur K BodvarsdottirJorunn E Eyfjord
Dec 14, 2011·Genome Integrity·Ester SapirPredrag Slijepcevic
Dec 22, 2011·The Journal of Biological Chemistry·Jaewon MinHyunsook Lee
Jan 24, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Yoo-Kyung LeeHyunsook Lee
May 11, 2012·Nucleic Acids Research·Brian BudkePhilip P Connell
Dec 3, 2014·Experimental Cell Research·Hyunsook Lee
Jan 6, 2015·Cell·Sylvia F BojDavid A Tuveson
Sep 12, 2015·Nucleic Acids Research·Kumar SomyajitGanesh Nagaraju
Jan 20, 2016·PloS One·Katherine SullivanTomasz Skorski
Nov 4, 2016·Nature·Robert L DilleyRoger A Greenberg
Dec 17, 2016·Molecular Cell·Rahul BhowmickIan D Hickson
Dec 17, 2016·Molecular Cell·Sotirios K SotiriouThanos D Halazonetis

❮ Previous
Next ❯

Citations

Jul 11, 2020·DNA Repair·Susanna Stroik, Eric A Hendrickson
Dec 10, 2020·Seminars in Cell & Developmental Biology·Jennifer J LeeHyunsook Lee
Sep 10, 2021·Nucleic Acids Research·Abhishek Bharadwaj SharmaEric Van Dyck
Nov 16, 2021·PLoS Genetics·William A ScottEric I Campos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.